日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Predicting the response of multiple myeloma to the proteasome inhibitor Bortezomib by evaluation of the unfolded protein response

通过评估未折叠蛋白反应预测多发性骨髓瘤对蛋白酶体抑制剂硼替佐米的反应

Nikesitch, N; Tao, C; Lai, K; Killingsworth, M; Bae, S; Wang, M; Harrison, S; Roberts, T L; Ling, S C W

Downregulation of renal tubular Wnt/β-catenin signaling by Dickkopf-3 induces tubular cell death in proteinuric nephropathy

Dickkopf-3 下调肾小管 Wnt/β-catenin 信号传导,导致蛋白尿性肾病中的肾小管细胞死亡

D W L Wong, W H Yiu, H J Wu, R X Li, Y Liu, K W Chan, J C K Leung, L Y Y Chan, K N Lai, S C W Tang

First report of peritoneal dialysis-related peritonitis caused by Citrobacter amalonaticus

首例由阿马隆柠檬酸杆菌引起的腹膜透析相关性腹膜炎报告

Wong, M Y; Lau, S K P; Tang, S C W; Curreem, S O T; Woo, P C Y; Yuen, K Y

A staged approach with vincristine, adriamycin, and dexamethasone followed by bortezomib, thalidomide, and dexamethasone before autologous hematopoietic stem cell transplantation in the treatment of newly diagnosed multiple myeloma

对于新诊断的多发性骨髓瘤,采用分阶段治疗方案,先使用长春新碱、阿霉素和地塞米松,然后使用硼替佐米、沙利度胺和地塞米松,最后进行自体造血干细胞移植。

Chim, C S; Lie, A K W; Chan, E Y T; Leung, Y Y; Cheung, S C W; Chan, S Y T; Liang, Raymond; Kwong, Y L

Differential expression of receptors for advanced glycation end-products in peritoneal mesothelial cells exposed to glucose degradation products.

暴露于葡萄糖降解产物的腹膜间皮细胞中晚期糖基化终产物受体的差异表达

Lai K N, Leung J C K, Chan L Y Y, Li F F K, Tang S C W, Lam M F, Tse K C, Yip T P, Chan T M, Wieslander A, Vlassara H